Clinical trial Recruiting at 1 site Interventional Ages 18 to 50

Latissimus dorsi strengthening for rotator cuff tendinopathy

Official title: Effects of Latissimus Dorsi Exercises on Acromiohumeral Interval, Pain, and Function in Rotator Cuff Tendinopathy

Run by Hacettepe University · NCT07053566 · Data updated 2026-11-12

Researchers will test whether adding latissimus dorsi exercises helps people with rotator cuff tendinopathy improve shoulder function and reduce pain.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexAll
Enrollment47 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedMay 23, 2025
Main results expectedMay 22, 2027
Study endsSeptember 22, 2027
Registry record updatedOctober 22, 2026
Trial IDNCT07053566 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–50 with ultrasound-confirmed rotator cuff tendinopathy and measurable shoulder pain during activity, meeting specific exam criteria.

Probably not a fit

Individuals with full-thickness rotator cuff tears, prior shoulder surgery on the symptomatic side, or significant comorbidities may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study randomizes 47 adults aged 18–50 with rotator cuff tendinopathy into three groups: rotator cuff–only strengthening, latissimus dorsi–only strengthening, or a combined program, over 12 weeks. Outcomes include changes in acromiohumeral distance, shoulder function, and pain. The trial aims to see if increasing latissimus dorsi activation improves subacromial space and clinical symptoms by promoting humeral head inferior glide. Eligibility requires ultrasound-confirmed tendinopathy, persistent activity-related pain, and specific shoulder exam criteria. The study is conducted at Hacettepe University in Ankara under a single lead sponsor.

Why it matters

Potential benefit: If successful, the approach could offer a targeted exercise strategy to relieve pain and improve shoulder function for people with rotator cuff tendinopathy.

How similar studies have gone: Previous research supports strengthening-based rehabilitation for rotator cuff disorders, but this specific latissimus dorsi–focused approach is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 50 years
* At least 3 months of ongoing shoulder pain
* At least 3 positive tests out of 5 (Neer, Hawkins-Kennedy, Jobe, Painful Arc Sign, Pain on Resisted External Rotation)
* Ultrasound diagnosis of rotator cuff tendinopathy
* Shoulder pain during activity rated greater than 3 out of 10 on the Numeric Pain Scale
* Central Sensitization Inventory score below 40

Exclusion Criteria:

* Bilateral shoulder pain
* History of surgery or dislocation in the symptomatic shoulder
* Acromioclavicular degeneration
* Presence of shoulder capsulitis (restriction in passive glenohumeral range of motion in 2 or more directions)
* Full-thickness rotator cuff tear
* Shoulder osteoarthritis, rheumatoid arthritis, systemic inflammatory or neurological disease
* Any injection to the symptomatic shoulder within the past 6 weeks
* BMI greater than 30 kg/m2
* Refusal to participate in the study

Where it's running

  • Hacettepe University Faculty of Physical Therapy and Rehabilitation
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.